Kihara James (CIK 1816160) reported 20 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-07). Recent activity: Buy ACAD (2,010 shares), Sell ACAD (1,030 shares), Buy ACAD (1,627 shares), Sell ACAD (833 shares), Buy ACAD (2,142 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-07 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Buy | 2,010 | $0 |
| 2026-04-07 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Sell | 1,030 | $22,866 |
| 2026-03-26 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Buy | 1,627 | $0 |
| 2026-03-26 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Sell | 833 | $17,885 |
| 2026-03-26 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Buy | 2,142 | $0 |
| 2026-03-26 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Sell | 1,097 | $23,750 |
| 2026-03-26 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Sell | 12 | $261 |
| 2025-11-19 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Buy | 3,966 | $0 |
| 2025-11-19 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Buy | 3,966 | $0 |
| 2025-11-19 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Sell | 4,084 | $96,750 |
| 2025-05-19 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Sell | 2,000 | $50,000 |
| 2025-05-19 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Sell | 2,000 | $40,000 |
| 2025-05-02 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Buy | 2,596 | $0 |
| 2025-05-02 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Sell | 1,327 | $19,374 |
| 2025-04-08 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Buy | 2,010 | $0 |
| 2025-04-08 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Sell | 1,028 | $15,235 |
| 2025-03-26 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Buy | 2,142 | $0 |
| 2025-03-26 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Sell | 1,095 | $18,670 |
| 2025-02-25 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Buy | 840 | $0 |
| 2025-02-25 | ACADIA PHARMACEUTICALS INC (ACAD) | PRINCIPAL ACCOUNTING OFFICER | Sell | 475 | $9,481 |
Source: SEC Form 4 filings · as of 2026-04-07